Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

CA (BC): Lab in development at Delta 9

NanoSphere Health Sciences has started working on the production facility for NanoSphere’s products in Canada, based at the Delta 9 Cannabis Inc. facility in Winnipeg, Manitoba.

“We’re working hard to get production underway in April, with the goal of getting final approval for the first sales of NanoSphere products before summer,” says NanoSphere CEO Robert Sutton. “This will be the first time our cannabis-related products will be sold outside the United States, so it’s a major and very exciting step for the Company.”

"Recently awarded U.S. Patent No. 10,028,919, NanoSphere has been granted market exclusivity over the standardized delivery of cannabis through phospholipid nanoparticle technology, known as the NanoSphere Delivery System," the company points out.

"Delta 9’s construction team have now constructed and put in place the proprietary Delta 9 Grow Pods, adapted to provide laboratory and production space for the NanoSphere product lines. Most of the lab equipment has arrived at the Winnipeg facility, and NanoSphere’s science team has prepared a custom formulation that meets Health Canada’s stringent requirements."

"NanoSphere’s groundbreaking delivery system works by nano-encapsulating active ingredients in phospholipid membranes for transportation through the skin and mucosa into the bloodstream within minutes. Cannabis applications of the technology into intraoral products will provide rapid results, precise dosages and high bioavailability. This advancement eliminates the need for inhalation or ingestion of cannabis, offering users a safer and more effective method of consumption.", the team with the company explains. .

“NanoSphere products provide for the first time an effective way to deliver medical cannabis, with precise dosage, better bio-availability, and without essentially having to ‘smoke your medicine’,” Gary Symons, President of the Company’s cannabis division, NanoSphere Cannabis International, says. 

"The NanoSphere team expects to be in Winnipeg in late March and early April to facilitate the final installation of the necessary equipment, and to train Delta 9 staff in the production process.", the company concludes. 

Publication date: